Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 3
1954 1
1957 1
1961 2
1980 1
1985 2
1986 20
1987 115
1988 231
1989 415
1990 548
1991 591
1992 653
1993 610
1994 604
1995 687
1996 674
1997 630
1998 667
1999 585
2000 528
2001 429
2002 351
2003 337
2004 301
2005 318
2006 288
2007 368
2008 309
2009 290
2010 321
2011 273
2012 264
2013 246
2014 222
2015 211
2016 215
2017 182
2018 160
2019 135
2020 150
2021 134
2022 117
2023 96
2024 84
2025 81
2026 67

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,068 results

Results by year

Filters applied: . Clear all
Page 1
Zidovudine (Retrovir) update.
Rachlis AR. Rachlis AR. CMAJ. 1990 Dec 1;143(11):1177-85. CMAJ. 1990. PMID: 2224694 Free PMC article. Review.
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. ...After a search of MEDLINE for pertinent articles published since 1985, controlled studies and studies of long-term zidovudine ther …
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. …
Zidovudine intolerance.
Groopman JE. Groopman JE. Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S500-6. doi: 10.1093/clinids/12.supplement_5.s500. Rev Infect Dis. 1990. PMID: 2201071 Review.
Patients may be intolerant of zidovudine for several reasons, the most prominent being hematologic toxicity. In vitro studies demonstrate that zidovudine is toxic to the myeloid and erythroid precursors in the bone marrow; at concentrations of zidovudine near …
Patients may be intolerant of zidovudine for several reasons, the most prominent being hematologic toxicity. In vitro studies demonst …
Antiretroviral agents.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 2000;76:45-173. IARC Monogr Eval Carcinog Risks Hum. 2000. PMID: 11000975 Free PMC article. Review. No abstract available.
Intermittent therapy.
Volberding PA. Volberding PA. J Acquir Immune Defic Syndr (1988). 1994 May;7(5):454-6. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8158538 No abstract available.
AIDS therapies.
Yarchoan R, Mitsuya H, Broder S. Yarchoan R, et al. Sci Am. 1988 Oct;259(4):110-9. doi: 10.1038/scientificamerican1088-110. Sci Am. 1988. PMID: 3072667 Review. No abstract available.
Lamivudine/zidovudine/abacavir: triple combination tablet.
Ibbotson T, Perry CM. Ibbotson T, et al. Drugs. 2003;63(11):1089-98; discussion 1099-1100. doi: 10.2165/00003495-200363110-00010. Drugs. 2003. PMID: 12749741 Review.
Two studies in treatment-naive patients (one double-blind, one nonblind) have reported that lamivudine/zidovudine (dual combination tablet) plus abacavir showed efficacy similar to that of lamivudine/zidovudine plus indinavir. ...Treatment-naive patients receiving l …
Two studies in treatment-naive patients (one double-blind, one nonblind) have reported that lamivudine/zidovudine (dual combination t …
Zidovudine.
[No authors listed] [No authors listed] Nurs Times. 2005 Nov 29-Dec 5;101(48):33. Nurs Times. 2005. PMID: 16350517 No abstract available.
Zidovudine--AZT.
Manser A. Manser A. Aust Nurses J. 1989 Apr;18(9):37. Aust Nurses J. 1989. PMID: 2712762 No abstract available.
Lessons from the Concorde trial.
Peto T, Darbyshire J. Peto T, et al. Br J Hosp Med. 1994 Oct 19-Nov 1;52(8):378-9. Br J Hosp Med. 1994. PMID: 7858826 Clinical Trial. No abstract available.
Zidovudine-induced leukocytoclastic vasculitis.
Torres RA, Lin RY, Lee M, Barr MR. Torres RA, et al. Arch Intern Med. 1992 Apr;152(4):850-1. Arch Intern Med. 1992. PMID: 1558446
Cutaneous reactions, including acne, pruritus, urticaria, and nail dyschromia, have been associated with zidovudine use. Cutaneous leukocytoclastic vasculitis is characterized by distinctive patterns of dermal perivascular inflammation without visceral involvement. We trea …
Cutaneous reactions, including acne, pruritus, urticaria, and nail dyschromia, have been associated with zidovudine use. Cutaneous le …
13,068 results
You have reached the last available page of results. Please see the User Guide for more information.